Le Lézard
Classified in: Covid-19 virus
Subject: ATY

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Beyond Meat Investors of a Lead Plaintiff Deadline of July 10, 2023


NEW YORK, June 5, 2023 /PRNewswire/ -- Attention Beyond Meat, Inc. ("Beyond Meat") (NASDAQ: BYND) shareholders:

The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purchased between May 5, 2020 and October 13, 2022.

If you suffered a loss on your investment in Beyond Meat, contact us about potential recovery by using the link below. There is no cost or obligation to you.

https://www.wongesq.com/pslra-1/beyond-meat-class-action-submission-form?prid=40253&wire=4

ABOUT THE ACTION: According to the complaint, throughout the Class Period defendants made numerous materially false and misleading statements and omissions concerning the Company's ability to produce plant-based meats at scale. Specifically, defendants repeatedly assured investors that Beyond Meat conducted "extensive testing" to "ensure manufacturability" of its plant-based meat products at commercial scale, and touted the success of the Company's product tests with its large-scale partnerships as "very positive." Further, defendants blamed any delays in launching these large-scale partnerships on Covid-19.

DEADLINE: July 10, 2023

Aggrieved Beyond Meat investors only have until July 10, 2023 to request that the Court appoint you as lead plaintiff. You are not required to act as a lead plaintiff in order to share in any recovery.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
E-Mail: [email protected]

SOURCE The Law Offices of Vincent Wong


These press releases may also interest you

at 08:20
Coya Therapeutics, Inc. ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, announces that Dr. Stanley Appel, M.D., Chairman of Coya's Scientific Advisory...

at 08:09
Adyton Resources Corporation announces that it has filed its financial statements for the three and twelve months ended December 31, 2023 and accompanying Management Discussion and Analysis on its SEDAR profile at www.sedar.com. ...

at 08:05
Gilead Sciences, Inc. today announced the U.S. Food and Drug Administration (FDA) approved an updated label with additional data reinforcing the safety and efficacy profile of Biktarvy® (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide...

at 08:00
The "Global Men's Health and Wellness Market: Analysis By Type, By Distribution Channel, By Region Size & Forecast with Impact Analysis of COVID-19 and Forecast up to 2029" report has been added to ResearchAndMarkets.com's offering. In 2023, the...

at 08:00
Citius Pharmaceuticals Inc. ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today announced that it has entered into definitive...

at 07:40
The "Global Weight Loss Drugs Market: Analysis By Product Type, By Drug Type, By Distribution Channel, By End User, By Region, Size and Trends with Impact of COVID-19 and Forecast up to 2029" report has been added to ResearchAndMarkets.com's...



News published on and distributed by: